{"SPADE_N_06174": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2023/0416797 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1", "Patent Type": "Patent Application", "Publication Date": "2023-12-28", "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1", "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE", "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."}], "Sequence Information": {"SPADE ID": "SPADE_N_06174", "Sequence": "WMAIRRILRCHPFHPGGYDPVPELGEHCCHHDSGNKG", "Sequence Length": 37, "Peptide Name": "Sequence 202 from US 20230416797", "Source": "Nostoc sp", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "GHP", "Absent Amino Acids": "OQTU", "Basic Residues": 9, "Acidic Residues": 4, "Hydrophobic Residues": 14, "Polar Residues": 17, "Positive Residues": 9, "Negative Residues": 4, "Mass": 4223.76, "PI": 7.13, "Net Charge": 5, "Hydrophobicity": -0.74, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06175", "Similarity": 0.9142857142857143, "Sequence": "WMGIRRILRCHPFHPGGYDPVPEVGEHCCHHDSGK"}, {"SPADE_ID": "SPADE_N_06177", "Similarity": 0.84375, "Sequence": "WMATLRILRCHPFHPGGYDPVPGLAEKSCCDHHD"}, {"SPADE_ID": "SPADE_N_06176", "Similarity": 0.6756756756756757, "Sequence": "WMATRRILRCHPFHPGGYDPVPEVKHNCCDQHLSDSGKQTTEDHHKGS"}]}}}